We are live on ! Find out more
LMAT icon

LeMaitre Vascular

87 hedge funds and large institutions have $124M invested in LeMaitre Vascular in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

43% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 23

16% more funds holding

Funds holding: 7587 (+12)

9% more capital invested

Capital invested by funds: $114M → $124M (+$10.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
87
Holders Change
+12
Holders Change %
+16%
% of All Funds
2.43%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
21
Increased
33
Reduced
23
Closed
9
Calls
Puts
Net Calls
Net Calls Change

LMAT Hedge Fund Activity: Q3 2015 in Review

87 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2015, worth a combined $124M — up 9.1% from $114M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LMAT positions and 9 closed out — a net gain of 12 holders — while 33 added to existing stakes and 23 trimmed.

The largest buyer was Driehaus Capital Management, adding an estimated $3.62M. The largest seller was William Blair & Company, cutting an estimated $5.49M.

  • 87 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2015, up from 75 in Q2 2015.
  • Funds reported $124M of LeMaitre Vascular stock for Q3 2015, up 9.1% quarter-over-quarter.
  • 21 funds opened new LeMaitre Vascular positions in Q3 2015 and 9 closed out, a net change of +12 holders.
  • The largest LeMaitre Vascular buyer in Q3 2015 was Driehaus Capital Management, an estimated $3.62M added.
  • The largest LeMaitre Vascular seller in Q3 2015 was William Blair & Company, an estimated $5.49M sold.

Based on aggregated 13F filings for Q3 2015.